Innovation in Analytical Instruments Trek Diagnostic Systems has demonstrated a strong focus on advancing analytical technology with the launch of the Vanquish Core HPLC systems in March 2020, indicating opportunities to offer complementary chromatography and analytical solutions to laboratory clients.

Strategic Acquisitions The acquisition of Pharmafluidics in November 2021 highlights Trekds's interest in microchip-based chromatography, presenting potential cross-selling opportunities for innovative chromatography consumables and microfluidic products to existing and new customers.

COVID-19 Testing Expansion The company's recent expansion of the K-12 ReadyCheckGo COVID-19 testing solution in Texas suggests increasing demand for rapid deployment of diagnostic testing kits, creating opportunities to supply testing reagents, kits, and related diagnostic equipment.

Focus on Large-Scale Testing Trekds’s launch of the Thermo Scientific Saliva Collection Kit in 2013 indicates an ongoing commitment to supporting large-scale research and surveillance programs, opening avenues to provide collection devices and sample management systems for public health and research institutions.

Growth Potential With a revenue range of 1 million to 10 million and recent product launches and acquisitions, Trekds presents a growth opportunity for suppliers of laboratory instruments, consumables, and diagnostic solutions targeting mid-sized medical equipment companies.